alpha-aminopyridine has been researched along with Lymphoma, Large B-Cell, Diffuse in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (44.44) | 24.3611 |
| 2020's | 10 (55.56) | 2.80 |
| Authors | Studies |
|---|---|
| Batlevi, CL; De Frank, S; Drullinsky, P; Gerecitano, JF; Hamilton, A; Hamlin, PA; Horwitz, SM; Kumar, A; Matasar, MJ; Michaud, L; Moskowitz, A; Moskowitz, CH; Nakajima, R; Nichols, C; Rademaker, J; Salles, G; Schöder, H; Seshan, V; Stewart, CM; Straus, D; Tsui, DWY; Whiting, K; Younes, A; Zelenetz, AD | 1 |
| Dong, T; Jing, F; Song, W; Wang, L; Wang, Y; Xiao, S; Xue, H | 1 |
| Ban, WW; Chang, Z; Chen, HZ; Guan, XW; Jia, L; Liu, FT; Wang, HQ | 1 |
| Chen, Z; Li, Y; Tian, C | 1 |
| Hu, S; Wang, W; Zhang, W; Zhang, Y; Zhou, D; Zou, D | 1 |
| Aguiar, RCT; Ethiraj, P; Holder, KN; Jiang, S; Lin, AP; Myers, J; Qiu, Z; Sasi, B | 1 |
| Bai, M; Chi, F; Li, Z; Mu, X; Qin, K; Su, L; Wang, L; Wang, Y; Yang, B; Yu, B; Zhang, H | 1 |
| Chung, JS; Kim, DY; Kim, SW; Nam, J; Shin, HJ | 1 |
| Chen, Y; Gao, J; Jia, Y; Ma, T; Wang, F; Wu, P; Zhou, Z | 1 |
| Bao, YH; Cai, HD; Guan, YQ; Shen, KF; Wang, JC; Xiao, M; Yang, L; Zhang, ML; Zhang, W; Zheng, M; Zhou, JF | 1 |
| Casellato, A; Macaccaro, P; Mandato, E; Nunes, SC; Piazza, F; Semenzato, G; Trentin, L; Tubi, LQ; Visentin, A; Zaffino, F | 1 |
| Barca, EG; Barrigon, DC; Bociek, RG; Gerecitano, J; Kim, WS; Kong, O; Martinelli, G; Pisal, CB; Salles, G; Tavorath, R; Turgut, M; Younes, A | 1 |
| Batchelor, TT; Grommes, C; Nayak, L; Tun, HW | 1 |
| Chen, J; Cheng, C; He, MX; Yang, D; Yang, JM; Zhang, WP | 1 |
| Huang, J; Li, Q; Li, Y; Ou, Y; Wu, Y | 1 |
| Coordes, A; Eucker, J; Lenarz, M; Liu, H; Possinger, K; Scholz, CW; Zang, C | 1 |
| Aguiar, RCT; Bhatnagar, H; Holder, KN; Kim, SW; Lin, AP; Moritz, AW; Suhasini, AN; Wang, L | 1 |
| Ardeshna, KM; Bartlett, NL; Blum, KA; Flinn, IW; Flowers, CR; Friedberg, JW; LaCasce, AS; Mitchell, P; Shustov, AR; Skolnik, JM; Thress, KS; Zheng, F | 1 |
1 review(s) available for alpha-aminopyridine and Lymphoma, Large B-Cell, Diffuse
| Article | Year |
|---|---|
Introduction of novel agents in the treatment of primary CNS lymphoma.
Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Aminopyridines; Antineoplastic Agents, Immunological; Burkitt Lymphoma; Central Nervous System Neoplasms; Humans; Immunologic Factors; Lenalidomide; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell; Morpholines; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Piperidines; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Rituximab; Salvage Therapy; Thalidomide; Toll-Like Receptors; TOR Serine-Threonine Kinases; Tumor Escape | 2019 |
3 trial(s) available for alpha-aminopyridine and Lymphoma, Large B-Cell, Diffuse
| Article | Year |
|---|---|
Phase I/Ib Study of the Efficacy and Safety of Buparlisib and Ibrutinib Therapy in MCL, FL, and DLBCL with Serial Cell-Free DNA Monitoring.
Topics: Adenine; Adult; Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Cell-Free Nucleic Acids; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Morpholines; Phosphatidylinositol 3-Kinases; Piperidines; Pyrazoles; Pyrimidines | 2022 |
Pan-phosphatidylinositol 3-kinase inhibition with buparlisib in patients with relapsed or refractory non-Hodgkin lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Aminopyridines; Female; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Morpholines; Phosphoinositide-3 Kinase Inhibitors; Recurrence; Remission Induction; Salvage Therapy | 2017 |
A phase II trial to evaluate the efficacy of fostamatinib in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL).
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Aminopyridines; Antineoplastic Agents; Disease Progression; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Humans; Intracellular Signaling Peptides and Proteins; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Morpholines; Oxazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyridines; Pyrimidines; Recurrence; Syk Kinase; Time Factors; Treatment Outcome; United States | 2016 |
14 other study(ies) available for alpha-aminopyridine and Lymphoma, Large B-Cell, Diffuse
| Article | Year |
|---|---|
Chidamide with PEL regimen (prednisone, etoposide, lenalidomide) for elderly or frail patients with relapsed/refractory diffuse large B-Cell lymphoma -results of a single center, retrospective cohort in China.
Topics: Aged; Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Etoposide; Frail Elderly; Histone Deacetylase Inhibitors; Humans; Lenalidomide; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Prednisone; Retrospective Studies; Rituximab | 2022 |
Novel HDAC inhibitor Chidamide synergizes with Rituximab to inhibit diffuse large B-cell lymphoma tumour growth by upregulating CD20.
Topics: Aminopyridines; Animals; Antigens, CD20; Apoptosis; Benzamides; Cell Line, Tumor; Cell Lineage; Cell Proliferation; Down-Regulation; Drug Synergism; Gene Expression Regulation, Neoplastic; Gene Ontology; Hematopoiesis; Histone Deacetylase Inhibitors; Humans; Lymphoma, Large B-Cell, Diffuse; Mice; Rituximab; RNA, Messenger; Signal Transduction; Transcriptome; Treatment Outcome; Up-Regulation; Xenograft Model Antitumor Assays | 2020 |
Chidamide combined with ibrutinib improved the prognosis of primary bone marrow diffuse large B cell lymphoma.
Topics: Adenine; Aged; Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bone Marrow; Bone Marrow Cells; China; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Piperidines; Prednisone; Prognosis; Rituximab; Transplantation, Autologous; Vincristine | 2020 |
Successful treatment with lenalidomide plus chidamide combination therapy in 3 heavily treated patients with non-Hodgkin lymphoma: Three cases report.
Topics: Aged; Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Female; Humans; Lenalidomide; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Salvage Therapy | 2020 |
Regulation of PD-L1 expression is a novel facet of cyclic-AMP-mediated immunosuppression.
Topics: Aminopyridines; Animals; B7-H1 Antigen; Benzamides; Cell Line, Tumor; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclopropanes; Gene Expression Regulation, Neoplastic; Humans; Immune Tolerance; Lymphocyte Activation; Lymphoma, Large B-Cell, Diffuse; Mice; Mice, Knockout; Phosphodiesterase 4 Inhibitors; Signal Transduction | 2021 |
Chidamide induces apoptosis in DLBCL cells by suppressing the HDACs/STAT3/Bcl‑2 pathway.
Topics: Aminopyridines; Apoptosis; Benzamides; Caspase 3; Cell Line, Tumor; Dose-Response Relationship, Drug; Gene Expression; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Isoenzymes; Lymphoma, Large B-Cell, Diffuse; Phosphorylation; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; STAT3 Transcription Factor | 2021 |
Role of Roflumilast Combined with ESHAP Chemotherapy in Relapsed/Refractory Patients with Diffuse Large B-Cell Lymphoma.
Topics: Aged; Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Cisplatin; Cyclopropanes; Cytarabine; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Methylprednisolone; Middle Aged; Phosphatidylinositol 3-Kinases; Phosphodiesterase 4 Inhibitors; Pilot Projects | 2022 |
Treatment of refractory diffuse large B-cell lymphoma by chidamide combined with autologous stem cell transplantation: a case report.
Topics: Adult; Aminopyridines; Antineoplastic Agents; Benzamides; Combined Modality Therapy; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse | 2021 |
[Treatment of relapsed and refractory EZB/C3 subtype DLBCL with chidamide in combination of R2-CHOP: a case report].
Topics: Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Humans; Lymphoma, Large B-Cell, Diffuse; Rituximab | 2021 |
CX-4945, a Selective Inhibitor of Casein Kinase 2, Synergizes with B Cell Receptor Signaling Inhibitors in Inducing Diffuse Large B Cell Lymphoma Cell Death.
Topics: Adenine; Aminopyridines; Apoptosis; Casein Kinase II; Cell Proliferation; Drug Synergism; Humans; Lymphoma, Large B-Cell, Diffuse; Morpholines; Naphthyridines; Oxazines; Phenazines; Piperidines; Pyrazoles; Pyridines; Pyrimidines; Receptors, Antigen, B-Cell; Tumor Cells, Cultured | 2018 |
Secondary skin involvement in gastric diffuse large B-cell lymphoma treated with chidamide: A case report.
Topics: Aminopyridines; Antineoplastic Agents; Benzamides; Diagnosis, Differential; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Skin Neoplasms; Stomach Neoplasms | 2018 |
Progressive diffuse large B-cell lymphoma with TP53 gene mutation treated with chidamide-based chemotherapy.
Topics: Aged; Aminopyridines; Antigens, CD20; Antineoplastic Agents; Benzamides; Cell Line; Gene Expression Regulation, Neoplastic; Humans; Immunologic Factors; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Mutation; RNA, Messenger; Tumor Suppressor Protein p53; Up-Regulation | 2019 |
Inhibition of pan-class I phosphatidyl-inositol-3-kinase by NVP-BKM120 effectively blocks proliferation and induces cell death in diffuse large B-cell lymphoma.
Topics: Aminopyridines; Apoptosis; Autophagy; bcl-X Protein; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Class I Phosphatidylinositol 3-Kinases; Dose-Response Relationship, Drug; Flow Cytometry; Humans; Lymphoma, Large B-Cell, Diffuse; Morpholines; Myeloid Cell Leukemia Sequence 1 Protein; Protein Biosynthesis; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases; Tumor Cells, Cultured | 2014 |
A phosphodiesterase 4B-dependent interplay between tumor cells and the microenvironment regulates angiogenesis in B-cell lymphoma.
Topics: Aminopyridines; Animals; B-Lymphocytes; Benzamides; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclopropanes; Disease Models, Animal; Gene Expression Regulation, Neoplastic; Humans; Lymphoma, Large B-Cell, Diffuse; Mice; Mice, Transgenic; Neovascularization, Pathologic; Phosphatidylinositol 3-Kinases; Phosphodiesterase 4 Inhibitors; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Signal Transduction; Tumor Microenvironment; Vascular Endothelial Growth Factor A | 2016 |